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Letters to the Editorother long-term studies are difficult
because of differing baseline charac-
teristics.1 Comparisons are subse-
quently provided and summarized in
Table 5; however, considerations con-
cerning some key patient cohort dif-
ferences are lacking.2-4 These include
the following.
First, the continuing patient enroll-
ment during a 20-year period resulted
in a limited mean follow-up time:
6.0 4.5 years for aortic valve replace-
ment (AVR) and 6.2  5.6 years for
mitral valve replacement. This strategy
tends to underestimate events in
comparison with similar studies with
a much shorter enrollment period like
the cited 20-year Edwards Clinical
Communique´, which had a mean
follow-up time of 9.0  5.5 years.2
Second, the authors report the actu-
arial freedom from reoperation because
of structural valve deterioration (SVD),
which is inherently lower than the free-
dom from SVD. Therefore the direct
comparison with the freedom from
SVD as reported by several other stud-
ies tends to underestimate the number
of events in the current study.3,4
Third, the long inclusion period has
resulted in an uneven age distribution
over time. Given the mean age differ-
ence between the originally reported
10-year experience and the current
20-year report, patients in the AVR
and mitral valve replacement cohorts,
respectively, must on average have
been about 7 and 5 years older during
the second decade of the study than dur-
ing the first decade.1,5 Therefore a high
number of patients with a relatively
short follow-up time might contribute
to an underestimation of the incidence
of SVD in the elderly groups.2
A further comment is directed at the
intriguing incompleteness of Table 5.1
Age-stratified event rates for AVR
from several studies are cited in the
last column, headed by the Biocor’s
20-year freedom from reoperation be-
cause of SVD being 92.1%  3.9%
in patients aged 65 years and older andThe Journal44.5%  9.2% in those younger than
65 years. However, for 2 studies these
readily available data are provided as
mean overall rates only.3,4 The excel-
lence of these results in the elderly pa-
tient groups makes these data
indispensable for the overall perspec-
tive. The 68%  12% overall freedom
from SVD in Aupart and colleagues’
18-year Perimount experience3 thus
breaks down into 99%  1% for pa-
tients aged greater than 70 years, 77%
 12% for those aged 60 to 70 years,
and 45%  15% for those aged less
than 60 years. InYankah and associates’
17-year Mitroflow experience,4 the
67.0%  4.9% freedom from SVD in
similar age groups breaks down into
93.0%  3.0%, 60.1%  6.4%, and
45.7%  13.5%, respectively.
We congratulate the authors with
the realization of their study spanning
so many years and hope to see further
results and adequate comparisons in
future publications.
Willem J.L. Suyker, MD, PhD
Frans G. Leicher, MD
Department of Cardiothoracic
Surgery
Isala Clinics
Zwolle, The NetherlandsReferences
1. Myke´n PS, Bech-Hansen O. A 20-year experience
of 1712 patients with the Biocor porcine bioprosthe-
sis. J Thorac Cardiovasc Surg. 2009;137:76-81.
2. Clinical Communique´: Carpentier-Edwards Peri-
mount pericardial aortic bioprosthesis 20 year results.
Irvine, Calif: Edwards Lifesciences; 2003. Available
at: http://www.edwards.com/products/heartvalves/peri
mountaorticcommuniquepdf.htm. Accessed April 6,
2009.
3. Aupart MR, Mirza A, Meurisse YA, Sirinelli AL,
Neville PH, Marchand MA. Perimount pericardial
bioprosthesis for aortic calcified stenosis: 18-year
experience with 1,133 patients. J Heart Valve Dis.
2006;15:768-76.
4. Yankah CA, Schubel J, Buz S, Siniawski H,
Hetzer R. Seventeen-year clinical results of 1,037
Mitroflow pericardial heart valve prostheses in the
aortic position. J Heart Valve Dis. 2005;14:172-9.
5. Myke´n PS, Caidahl K, Larsson S, Berggren HE.
10-year experience with the Biocor porcine biopros-
thesis in the aortic position. J Heart Valve Dis. 1994;
3:648-56.
doi:10.1016/j.jtcvs.2009.04.070of Thoracic and Cardiovascular SurgerTHE SECOND ASSISTANT IN
CARDIAC SURGERY
To the Editor:
I thank Dr Zamvar for his apprecia-
tive comments1 on my editorial entitled
‘‘The second assistant in cardiac sur-
gery: the challenges and answers.’’2
As Dr Zamvar rightly points out, the
position of second assistant is to be
seen as a great opportunity for surgical
training and not a burden. As surgical
trainees, we often have the mindset
that surgical training is all about cutting
and suturing, of doing rather than
watching. The second assistant position
in a way enforces a temporary pause in
this ‘‘cutting and suturing’’ ritual, al-
lowing the trainee to think and redefine
his or her techniques. Indeed, it is very
easy for the mind to drift, and the
trainee has to make a conscious effort
to stay focused. The ability to make
sharp observations and stay focused
for long durations is often not an innate
skill and has to be developed over time.
These mental faculties are as important
as hand skills in the making of a good
surgeon. The second assistant position
offers a unique opportunity to develop
these skills. I also agree with Dr Zam-
var that the new laws enforcing limited
hours of working on trainees3 will take
away a great opportunity from the cur-
rent generation of surgical trainees.
T. K. Susheel Kumar, MD
Department of Cardiovascular
Surgery
Children’s National Medical Centre
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